Condition
Lung Cancer|Mesothelioma
Estimated Enrollment: 22
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 2010-0057|NCI-2011-02080
Study First Received: May 27, 2010
Last Updated: November 9, 2016
Estimated Primary Completion Date: May 2018
Primary Outcome Measures:
Maximum Tolerated Dose (MTD) of IMRT after radical pleurectomy/decortication (PD)
Sponsors and Collaborators:
M.D. Anderson Cancer Center
Website Link: https://ClinicalTrials.gov/show/NCT01134146
